福西诺普里尔通过诱导NSCLC中的GSDME-依赖性烧来调解抗瘤功效
Yue Gao1, Xinyue Zhai2, Caixia Zhang3
1Department of Clinical Laboratory, Binzhou Medical University Hospital, Binzhou, China.
Cell death discovery
|November 21, 2025
概括
高血压药物西诺普利在治疗非小细胞肺癌 (NSCLC) 中表现有前途. 它抑制了癌细胞的生长,并通过热致死触发了细胞死亡,为NSCLC患者提供了新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 药物重新定位是癌症治疗的一个关键策略.
- 西诺普里尔是一种血管激素转化酶抑制剂 (ACEI),已被批准用于高血压.
- 西诺普利的抗癌作用在肝癌中已知,但在非小细胞肺癌 (NSCLC) 中尚未得到充分研究.
研究的目的:
- 在体外和体内研究西诺普利尔对抗NSCLC的作用.
- 阐明福西诺普利尔在NSCLC中的作用背后的分子机制.
主要方法:
- 评估了福西诺普利尔对A549和H1299NSCLC细胞系的抗增殖作用.
- 利用网络药理学和蛋白质组学来预测分子机制.
- 在裸体小鼠中使用皮下异种移植模型评估体内抗癌效应和机制.
主要成果:
- 福西诺普里尔显著抑制了NSCLC细胞的增殖和殖民地形成.
- 福西诺皮尔诱导NSCLC细胞中的热,由GSDME裂变和增加LDH释放表明.
- 福西诺普利在体内抑制了瘤生长,并激活了与热死相关的蛋白质.
结论:
- 福西诺普利尔通过GSDME-依赖性热灭菌抑制NSCLC.
- 该机制涉及ROS诱导的线粒体功能障碍和酶激活.
- 福西诺普里尔是NSCLC的潜在治疗剂,需要进一步研究.
更多相关视频
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
410
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.5K
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K